Neoadjuvant treatment strategies in 2025
November 16, 2025Read moreWhat are the goals for neoadjuvant chemotherapy (NAC) in renal cell carcinoma (RCC)? Prof. Jens Bedke (DE) provided important...
00
Highlights from Day 3
November 15, 2025Read moreBelow you can review some of the key topics covered at the EMUC25 Congress today. We share webcasts, session...
Treatment challenges in MIBC: ctDNA, EV-P cost and access
November 15, 2025Read moreIn his EMUC25 lecture ‘ctDNA in muscle-invasive bladder cancer: Ready for prime time?’ Prof. Lars Dyrskjøt (DK) shared data...
EMUC25 examines BRCA and PRS in hereditary GU cancers session
November 15, 2025Read moreWhat are the current updates regarding the significantly elevated prostate cancer (PCa) risk in individuals with BRCA mutations? What...
The big PCa game-changers for 2025
November 15, 2025Read moreIn an auditorium packed to capacity, Dr. Elena Castro (ES), Prof. Axel Merseburger (DE), and Dr. Alison Tree (GB),...
EMUC25: Day 2 highlights
November 14, 2025Read moreCheck out some highlights below from Day 2 at EMUC25, including session reports, webcasts, award winners and photo impressions....
Strategies in NMIBC: BCG failure, biomarkers and cost-effective treatments
November 14, 2025Read moreFollowing lively multidisciplinary case discussions in Plenary Session 4 at EMUC25, which covered multiple carcinoma in situ (CIS), as...
Wilms tumour in adults?
November 14, 2025Read moreDuring “Plenary Session 3: Rare genitourinary tumours and unconventional pathologies” held today, pathologist Prof. Rodolfo Montironi (IT) presented a...
EMUC25 invokes mindset shift toward sustainability
November 14, 2025Read more“Healthcare is the fifth largest producer of greenhouse gases in the world” was a recurring claim in Plenary Session...
